Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
PTX-9908 by Pertinax Therapeutics for Liver Cancer: Likelihood of Approval
PTX-9908 is under clinical development by Pertinax Therapeutics and currently in Phase II for Liver Cancer. According to GlobalData, Phase...